Forte® bifidumbacterium

General characteristics. Structure:

Active ingredient: not less than 50 million colony-forming units (^5x107, WHICH) bifidobacteria.

Excipients: lactoses monohydrate.

Pharmacological properties:

Pharmacodynamics. Effect of drug is caused by high concentration of the bifidobacteria (Bifidobacterium bifidum) occluded on particles of absorbent carbon, being antagonists of a wide range pathogenic (shigellas, salmonellas, golden staphylococcus, etc.) and conditionally pathogenic microorganisms (proteas, a klebsiyell, etc.).

Microcolonies of sorbed bifidobacteria provide bystry recovery of normal microflora which, being a natural biosorbent, accumulates the toxic substances getting from the outside or formed in an organism in a significant amount.

Sorbed bifidobacteria activate recovery processes in mucous membranes, pristenochny digestion, synthesis of vitamins and amino acids, strengthen a host defense of an organism.

Indications to use:

• intestinal dysbioses of various etiology (including caused by reception of antibiotics, antibacterial drugs, glucocorticosteroid hormones, the drugs having ulcerogenic effect on digestive tract);
• acute intestinal infections established (a shigellosis, a salmonellosis, a staphylococcal coloenteritis, a rotavirusny infection) and an unspecified etiology;
• food toxicoinfections.

As a part of complex therapy of the diseases which are followed by an intestinal dysbiosis:

• chronic diseases with a gastrointestinal tract disease (a peptic ulcer of a stomach and duodenum, pancreatitis, cholecystitis, diseases of a liver and biliary tract, chronic locks, a sprue);
• allergic diseases;
• pneumonia, acute and chronic bronchitis;
• acute respiratory viral infections;
• infectious mononucleosis;
• inflammatory diseases of an urogenital path;
• at patients of a surgical profile during preoperative preparation and after intestines, liver, pancreas operations for correction of a microbiocenosis of intestines and prevention of pyoinflammatory diseases.

Drug is used for prevention:

• intra hospital infections in maternity homes and hospitals;
• dysbacterioses at often ill SARS of children and adults.

Route of administration and doses:

Drug is used to children since the birth (including premature), the adult of all age groups.

Depending on weight of diseases Bifidumbacterium форте® is applied in the usual or increased doses.

Bifidumbacterium форте® with the medical purposes in usual doses:

• to children till 1 year on 1 package 2-3 times a day,
• to children since 1 on 1 package 3-4 times a day are also more senior,
• the adult on 2 packages 2-3 times a day.

Course of treatment at acute intestinal infections and food toxicoinfections of 5-7 days, at other diseases 15-21 days (is defined by character and disease severity). If necessary it is possible to repeat a course of treatment 2-3 times, each course is conducted in a month after the termination of the previous course of treatment.

The patient with surgical pathology – within 3-5 days before operation and within 10-15 days after operation:

• to children till 1 year on 1 package 3 times a day;
• to children since 1 on 1 package 3-4 times a day are also more senior;
• the adult on 2 packages 3 times a day.

Bifidumbacterium форте® with the medical purposes in the increased doses is appointed to children since 1 and the adult.

At acute intestinal infection and an acute respiratory viral infection since the first days of a disease:

• to children on 5 packages of 6 times a day;
• the adult on 10 packages 3 times a day.

Course of treatment 1-3 days depending on weight of a state.

At an infectious mononucleosis:

• to children up to 3 years on 3 packages 3 times a day, a course of 5 days; then 3 packages once in the evening, course of 5 days,
• to children from 3 to 7 years on 4 packages 3 times a day, a course of 5 days; then 4 packages once in the evening, course of 5 days,
• to children from 7 to 10 years on 6 packages 3 times a day, a course of 5 days; then 6 packages once in the evening, course of 5 days.
• to children 10 years on 7-8 packages 3 times a day, a course of 5 days are more senior; then 7-8 packages once in the evening, course of 5 days.

At chronic diseases of digestive tract:

• to children on 5 packages 1-3 times a day;
• the adult on 10 packages 1-3 times a day. Course of treatment of 10-14 days.

Patients with a diabetes mellitus need to consider that 5 packages of drug contain 0,35 XE.

With the preventive purposes to children till 1 year on 1 package of 1 times a day, all the rest on 1-2 packages 1-2 times a day. A preventive course is conducted by 10-15 days 2-3 times a year.

Bifidumbacterium форте® is accepted during meal, if necessary irrespective of meal. Drug before the use is mixed with liquid food, it is desirable fermented milk product, or a small amount of boiled water of room temperature for receiving a suspension with parts of a sorbent of black color. The received suspension (suspension) should be drunk, without trying to obtain full dissolution. Newborns and children of chest age can mix drug with maternal milk or mix for artificial feeding.

Features of use:

There are no precautionary measures.

Drug is allowed for use to women during the periods of pregnancy and breastfeeding. There are no special conditions of reception.

Drug does not influence ability to manage vehicles, mechanisms.

Side effects:

Are not established.

Interaction with other medicines:

At a concomitant use of Bifidumbacterium форте® with vitamins (especially groups B) effect of drug amplifies. At reception of antibiotics the recommended interval between reception of an antibiotic and the drug Bifidumbacterium форте® makes 3 – 4 hours.

Contraindications:

Inborn insufficiency of lactase. Glucose galactose absorption disturbance.

Overdose:

Cases of overdose were not observed.

Storage conditions:

To store at a temperature not above 10 °C. The lower bound of temperature is not limited. To store in the place, unavailable to children. A period of validity - 18 months. Drug is not suitable for use:

- after a period of validity;
- at outward change;
- at absence or indistinct marking on primary packaging;
- at disturbance of tightness of primary packaging.

Issue conditions:

Without recipe

Packaging:

Bifidumbacterium форте® powder for intake, 50 million, WHICH sorbed bifidobacteria in a package from multilayer metalpolymeric material. On 10 or 30 packages of the application instruction in a pack from a cardboard. In one package of 5 doses.